Neuropeptide Y Y2 receptor‐mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin‐sensitive mechanisms

@article{Yu1996NeuropeptideYY,
  title={Neuropeptide Y Y2 receptor‐mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin‐sensitive mechanisms},
  author={X J Yu and M. A. Moskowitz},
  journal={British Journal of Pharmacology},
  year={1996},
  volume={119}
}
  • X. YuM. A. Moskowitz
  • Published 1 September 1996
  • Biology, Medicine, Chemistry
  • British Journal of Pharmacology
1 The effects of neuropeptide Y (NPY) receptor agonists (administered intravenously) were examined on plasma protein ([125I]‐bovine serum albumin) leakage within dura mater evoked by unilateral trigeminal ganglion stimulation (0.6 mA, 5 ms, 5 Hz, 5 min), capsaicin (1 μmol kg−1, i.v.) or substance P (1 nmol kg−1, i.v.) in anaesthetized Sprague‐Dawley rats. 2 NPY (EC50: 5.6 nmol kg−1) and NPY fragment 13–36 [NPY (13–36)] (ED50: 4.3 nmol kg−1), an NPY Y2 receptor agonist, dose‐dependently… 

Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine

It is demonstrated that NPY dose dependently inhibits dural-evoked trigeminal activity, through NPY Y1 receptor activation, indicating antinociceptive actions of NPY in a migraine animal model.

Presynaptic neuropeptide receptors.

Presynaptic receptors for four families of neuropeptides will be discussed: opioids, neuropeptide Y, adrenocorticotropic hormone (ACTH), and orexins. Presynaptic receptors for the opioids (micro,

Cortical spreading depression and gene regulation: Relevance to migraine

CSD regulates genes that are intrinsic to its propagation, that identify accompanying vascular responses as a potential source of pain, and that protect against its potential pathological consequences, which have strong relevance to the mechanisms of migraine and its outcomes.

The role of gamma-aminobutyric acid in migraine pathogenesis

Evidence for the existence of a cause-effect relationship between impaired GABA metabolism and development of the disease is described and the pharmacodynamics of some GABA-positive drugs that are used for prophylactic and acute treatments of migraine, as well as other primary headaches are discussed.

Neurovascular mechanisms of migraine and cluster headache

  • J. HoffmannS. BacaS. Akerman
  • Biology, Medicine
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2019
The findings have shifted the understanding of these disorders to a primarily neuronal origin with the vascular manifestations being the consequence rather than the origin of trigeminal activation.

Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine

It is proposed that abnormalities in how estrogen modulates neuronal function in migraine are due to a mismatch between its gene-regulation and membrane effects.

References

SHOWING 1-10 OF 30 REFERENCES

Evidence for two neuropeptide Y receptors mediating vasoconstriction.

Further characterization of the putative 5‐HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

The above pharmacological data suggest that intracranial vessels possess 5‐HT receptor(s) which are coupled to inhibition of neurogenically‐mediated plasma protein extravasation.

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

The results demonstrate an important action of GR43175 on neurogenic mechanisms in dural blood vessels and suggest that drugs useful in the treatment of acute vascular headaches may share a similar mechanism of action.

Peripheral GABAA receptor‐mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

It is concluded that sodium valproate blocks plasma extravasation in the meninges through GABAA‐mediated postjunctional receptors probably within theMeninges.

Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways.

It is concluded that NPY inhibits neurogenic inflammation by prejunctional inhibition of neuropeptide release from airway sensory nerve terminals terminals by inhibiting neurogenic plasma extravasation in a dose-dependent manner.

Suppression by neuropeptide Y of capsaicin‐sensitive sensory nerve‐mediated contraction in guinea‐pig airways

It is suggested that NPY may act on the terminals of sensory neurones in the airways to prevent antidromic, excitatory neurotransmission by inhibiting transmitter release.

Prejunctional modulatory action of neuropeptide Y on peripheral terminals of capsaicin‐sensitive sensory nerves

It is concluded that NPY exerts a prejunctional inhibitory action on transmitter release from peripheral endings of capsaicin‐sensitive nerves and provides further evidence for the existence of two independent modes of activation of the ‘efferent’ function of Capsaicin-sensitive sensory nerves.

The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.

In the paw pressure test, NPY was not active, whereas the C-terminal fragments retained their potency and produced significant increases in the pressure required to evoke escape (NPY18-36: median effective dose = 18.7 nmol).

Some sensory neurons express neuropeptide Y receptors: potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury

  • P. MantyhC. Allen S. Vigna
  • Biology
    The Journal of neuroscience : the official journal of the Society for Neuroscience
  • 1994
NPY receptors are uniquely positioned to inhibit primary afferent nociceptors directly, especially after peripheral nerve injury, previous studies have demonstrated.

Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

Modifications at the amino‐ethyl side chain of sumatriptan dramatically enhance the suppression of c‐fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater.